Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 36
Titolo Data di pubblicazione Autori Tipo File Abstract
Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms 2011 Da Via' M. C. + Article (author) -
JAK2 GGCC haplotype in MPL mutated myeloproliferative neoplasms 2012 Da Vià M. C. + Article (author) -
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 2012 Da Via M. C. + Article (author) -
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1 2013 Da Vià M. C. + Article (author) -
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia 2014 Da Via M. C. + Article (author) -
Pre-Chemotherapy risk factors for invasive fungal diseases : Prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (seifem 2010-a multicenter study) 2015 Dà Via M. C. + Article (author) -
Minimal morphological criteria for defining bone marrow dysplasia : a basis for clinical implementation of WHO classification of myelodysplastic syndromes 2015 U. GianelliM. Da Via'CROCI, GIORGIO ALBERTO + Article (author) -
Successful treatment with Rituximab and Bendamustine in a patient with newly diagnosed Waldenström's Macroglobulinemia complicated by Bing-Neel syndrome 2015 Da Via MC. + Article (author) -
Emerging resistant bacteria strains in bloodstream infections of acute leukaemia patients : results of a prospective study by the Rete Ematologica Lombarda (Rel) 2016 Da Vià M. C.Mometto G. + Article (author) -
Protocol for M3P: A comprehensive and clinical oriented targeted sequencing panel for routine molecular analysis in multiple myeloma 2018 Da Via MC + Book Part (author) -
Hexokinase-2 Expression in MET-positive FDG-negative Multiple Myeloma 2018 Da Via MC + Article (author) -
Secondary acute myeloid leukaemia in elderly patients : Patient's fitness criteria and ELN prognostic stratification can be applied to guide treatment decisions : an analysis of 280 patients by the network rete ematologica lombarda (REL) 2018 E. BorlenghiC. BasilicoN. FracchiollaM. TurriniM. Da ViàE. SalaM. PetullàF. SeranaA. FerrarioA. Cortelezzi + Article (author) -
Molecular remission at the end of treatment is a necessary goal for a good outcome in ELN favorable-risk acute myeloid leukemia: a real-life analysis on 201 patients by the Rete Ematologica Lombarda network 2018 Fracchiolla N.Da Via MC. + Article (author) -
Spectrum and functional validation of PSMB5 mutations in multiple myeloma 2019 Da Vià M. C. + Article (author) -
Hierarchy of mono- And biallelic TP53 alterations in multiple myeloma cell fitness 2019 Da Vià M. C. + Article (author) -
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment 2019 M. C. Da Vià + Article (author) -
Gene expression comparison between the lymph node-positive and -negative reveals a peculiar immune microenvironment signature and a theranostic role for WNT targeting in pancreatic ductal adenocarcinoma: A pilot study 2019 Da Via MC. + Article (author) -
Comparison of 11C-Choline and 11C-Methionine PET/CT in Multiple Myeloma 2019 Da Via M. C. + Article (author) -
IKZF1/3 and CRL4CRBN E3 ubiquitin ligase mutations and resistance to immunomodulatory drugs in multiple myeloma 2020 Da Vià M. C. + Article (author) -
CIC mutation as a molecular mechanism of acquired resistance to combined braf-mek inhibition in extramedullary multiple myeloma with central nervous system involvement 2020 Da Via M. C. + Article (author) -
Mostrati risultati da 1 a 20 di 36
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile